Kucsera, Dániel
Tóth, Viktória E.
Sayour, Nabil V.
Kovács, Tamás
Gergely, Tamás G.
Ruppert, Mihály
Radovits, Tamás
Fábián, Alexandra
Kovács, Attila
Merkely, Béla
Ferdinandy, Péter
Varga, Zoltán V.
Funding for this research was provided by:
New National Excellence Program of the Ministry of Human Capacities (ÚNKP-21-3-II)
‘Az orvos-, egészségtudományi- és gyógyszerészképzés tudományos műhelyeinek fejlesztése’ (EFOP-3.6.3.-VEKOP-16-2017-00009)
Gedeon Richter Excellence PhD Scholarship
National Heart Program (NVKP_16-1-2016-0017)
Momentum Research Grant (LP-2021-14)
Horizon 2020 Research and Innovation Programme (739593)
Higher Education Institutional Excellence Programme of the Ministry for Innovation and Technology in Hungary (TKP/ITM/NKFIH)
National Research, Development and Innovation Office of Hungary (OTKA-FK-134751)
Article History
Received: 28 June 2022
Accepted: 21 December 2022
First Online: 7 January 2023
Competing interests
: PF is the founder and CEO of Pharmahungary, a group of R&D companies. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. AF and AK report personal fees from Argus Cognitive, Inc., outside the submitted work.